Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 5041 - 5048 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCN3048 | Atractylone |
|
1.Atractylone has inhibitory effects on mast cell-mediated allergic reactions, it regulates the degranulation of mast cell, proves its potential in the treatment of mast cell-mediated allergic reactions.
|
|
| BCN3049 | Anagyrine |
|
1. Anagyrine can induce red cell aplasia, vascular anomaly, and skeletal dysplasia.
2.(-)-Anagyrine and (-)--Methylcytisine have nematicidal activities against Pine Wood Nematodes. 3. Anagyrine, is the responsible teratogen from teratogenic lupins, can produce congenital deformities in calves typical of crooked calf disease. |
|
| BCN3050 | 3-Epioleanolic acid |
|
3-Epioleanolic acid and oleanonic acid possess varying degrees of agonist activity on uterine smooth muscle with minor changes in the molecular structure affecting its intrinsic activity on uterine muscle.
|
|
| BCN3051 | Phyltetralin |
|
1. Phyltetralin has antihyperuricemic activity.
|
|
| BCN3053 | Neoschaftoside |
|
1. Neoschaftoside has antioxidant activity.
|
|
| BCN3054 | Vitexin -4''-O-glucoside |
|
Vitexin-4''-O-glucoside could effectively protect ECV-304 cells against cytotoxicity induced by TBHP through resuming mitochondrial function.
|
|
| BCN3055 | Kuguacin J |
|
1. Kuguacin J exerts growth inhibition through G1 arrest and induction of apoptosis in androgen-dependent human prostate cancer, it is a promising candidate new antineoplastic and chemopreventive agent for androgen-dependent prostate cancer and carcinogenesis.
2. Kuguacin J modulates the function of P-glycoprotein (P-gp) by directly interacting at the drug-substrate-binding site, and it appears to be an effective inhibitor of P-gp activity in vitro and thus could be developed as an effective chemosensitizer to treat multidrug-resistant cancers. |
|
| BCN3056 | Kuguacin N |
|
Kuguacin N has antioxidant activity.
|
|